Standout Papers

Clinical Practice Guideline for Screening and... 2007 2026 2013 2019 2.1k
  1. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents (2017)
    Joseph T. Flynn, David C. Kaelber et al. PEDIATRICS
  2. Underdiagnosis of Hypertension in Children and Adolescents (2007)
    Matthew Hansen, Paul W. Gunn et al. JAMA
  3. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States (2020)
    David C. Kaelber, Rong Xu et al. Molecular Psychiatry
  4. Association of semaglutide with risk of suicidal ideation in a real-world cohort (2024)
    William Wang, Nora D. Volkow et al. Nature Medicine
  5. Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US (2022)
    Lindsey Wang, Nathan A. Berger et al. JAMA Pediatrics
  6. Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes (2024)
    Lindsey Wang, Rong Xu et al. JAMA Network Open
  7. Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population (2024)
    William Wang, Nora D. Volkow et al. Nature Communications
  8. Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes (2024)
    Lindsey Wang, Nathan A. Berger et al. Gastroenterology
  9. Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US (2024)
    William Yang Wang, Xin Qi et al. Alzheimer s & Dementia
  10. Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study (2024)
    William Yang Wang, Nora D. Volkow et al. Molecular Psychiatry
  11. Glucagon-like Peptide-1 Receptor Agonist Impact on Chronic Ocular Disease Including Age-Related Macular Degeneration (2025)
    Kevin Allan, David C. Kaelber et al. Ophthalmology

Immediate Impact

4 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

Pancreatic cancer
2025 Standout
GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
8 intermediate papers

Works of David C. Kaelber being referenced

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
2024 Standout
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
2024 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
David C. Kaelber 764 821 956 1560 1409 207 6.3k
Sean Hennessy 1057 970 623 1179 938 264 8.3k
Tom Marshall 832 1059 851 1532 1001 235 7.0k
Thomas A. Gaziano 813 1004 1087 2633 1868 156 7.7k
Kavumpurathu Raman Thankappan 256 990 1135 1083 1300 269 7.1k
Daniel C. Malone 695 897 306 985 791 284 7.6k
Tazeen H. Jafar 741 1089 1570 3366 1340 165 9.6k
Elizabeth A. Chrischilles 1886 1052 376 1148 1062 234 10.1k
Theodore Speroff 1548 1280 763 1675 1039 138 13.0k
Laura Plantinga 824 711 622 872 1091 176 6.2k
Michael A. Fischer 749 680 489 1058 1187 176 7.8k

All Works

Loading papers...

Rankless by CCL
2026